Theriva Biologics financials at a glance

+ Portfolio

The revenue of Theriva Biologics is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -1.31 Dollars per share in 2023, which was 31.05 higher than 2021. And about -4.0E-5 billion Dollars are reported as free cash flow in the financials of Theriva Biologics 2023. No dividends were paid to the shareholders of the Theriva Biologics stock NYSEAM:TOVX in the financial year 2023.

$0.00M

Revenue

$-1.31

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-1.31

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021	2017	2016	2015	2014	2013	2012	2011	2010	2008	2007
Rev.	Revenue	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	100.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-41.43%	0.00%	0.00%
EPS	Earnings Per Share	$-1.23	$-1.31	$-1.90	$-63.00	$-,143.99	$-,173.14	$-,112.00	$-94.50	$-,175.00	$-74.42	$-28.00	$-,122.50	$-,444.50
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	15.12M	15.84M	0.37M	0.33M	0.26M	0.21M	0.17M	0.13M	0.09M	0.07M	0.06M	0.06M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$-27.90M	$-38.89M	$0.00M	$-7.72M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$-28.47M	$-39.39M	$0.00M	$-7.76M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.14	$-1.25	$-1.06	$-57.46	$-,105.68	$-,170.83	$-91.12	$-59.43	$-89.52	$-36.31	$-18.08	$-82.59	$-,170.50

Theriva Biologics financials at a glance

Financials

Discover